Back to Search
Start Over
What's New in the Diagnosis and Treatment of Aspirin-Exacerbated Respiratory Disease: A Brief Review.
- Source :
- American Journal of Rhinology & Allergy; Mar2023, Vol. 37 Issue 2, p198-206, 9p
- Publication Year :
- 2023
-
Abstract
- Background: Aspirin-exacerbated respiratory disease (AERD) is a chronic condition characterized by the presence of asthma, chronic rhinosinusitis with nasal polyposis, and sensitivity to aspirin and other non-steroidal anti-inflammatory drugs. Diagnosis is based on careful clinical history and physical examination, characteristic laboratory and radiographic findings, and, in unclear cases, aspirin challenge. Established treatment is founded on comprehensive endoscopic sinus surgery followed by topical steroids and aspirin desensitization. T2 biologics are now available for refractory cases. Objective: To summarize the historic literature on AERD, its diagnosis and treatment options, as well as to review the most current publications on the topic and explore areas for future research. Methods: A literature review utilizing the PubMed database was performed. Results: Seminal journal articles regarding the diagnosis and treatment of AERD were reviewed with close attention to evidence-based protocols and knowledge gaps in the field as areas for future research. Conclusion: AERD is a complex disease which requires careful diagnostic work-up and coordinated care between the allergist and rhinologist to facilitate optimal treatment outcomes. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 19458924
- Volume :
- 37
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- American Journal of Rhinology & Allergy
- Publication Type :
- Academic Journal
- Accession number :
- 162143914
- Full Text :
- https://doi.org/10.1177/19458924221145254